DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/5b29d2/hemiplegia_global) has announced the addition of GlobalData's new report "Hemiplegia Global Clinical Trials Review, H2, 2011" to their offering.
GlobalData's clinical trial report, Hemiplegia Global Clinical Trials Review, H2, 2011" provides data on the Hemiplegia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemiplegia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hemiplegia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope:
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Key Topics Covered:
- Introduction
- Hemiplegia
- Report Guidance
- Clinical Trials by Region
- Clinical Trials by Country
- Top Countries Contributing to Clinical Trials in Asia-Pacific
- Top Five Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
- Top Countries Contributing to Clinical Trials in Middle East and Africa
- Clinical Trials by G7 Nations
- Clinical Trials in G7 Nations by Trial Status
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Unaccomplished Trials of Hemiplegia
- Subjects Recruited Over a Period of Time
- Prominent Sponsors
- Top Companies Participating in Hemiplegia Therapeutics Clinical Trials
- Prominent Drug Comparison
- Clinical Trial Profiles
- Clinical Trial Overview of Top Companies
- Five Key Clinical Profiles
- Appendix
- Abbreviations
- Definitions
- Research Methodology
- Secondary Research
For more information visit http://www.researchandmarkets.com/research/5b29d2/hemiplegia_global